Diagnostic accuracy of different bronchoscopic specimens in sputum Xpert MBT/RIF- negative pulmonary TB patients
Keywords:
Tuberculosis, bronchoscopy, bronchoalveolar lavage, Xpert MBT/RIF, trans-bronchial lung biopsyAbstract
Background: Tuberculosis (TB) control remains a critical public health problem worldwide. Rapid diagnosis and proper treatment are beneficial for the effective control of tuberculosis transmission. Diagnostic challenges arise when a patient has a clinical and radiological suspicion of tuberculosis but cannot produce sputum, sputum acid-fast bacilli, or Xpert Mycobacterium tuberculosis/rifampicin (Xpert MTB/RIF) is negative, resulting in suboptimal management. As a result, more invasive techniques must be used on these patients to establish the diagnosis.
Methods: A retrospective study recruited 330 suspected pulmonary TB patients with negative sputum of Xpert MBT/RIF who underwent bronchoscopy between March 2018 and December 2021. The diagnostic yields of bronchoalveolar lavage fluid (acid-fast bacilli, Xpert MTB/RIF, and culture) and histopathologic examination (HPE) were calculated and compared to the final diagnosis and culture as a gold standard.
Results: Out of 330 suspected pulmonary TB patients, 181 had a final diagnosis of TB, and 149 had non-TB. The sensitivity of BALF (culture, Xpert, acid-fast bacilli) and trans-bronchial lung biopsy (HPE) was 80.7%, 72.9%, 21.1%, and 87.1%, respectively. Multiple nodules were associated with significantly higher BALF Xpert MTB, bronchoalveolar lavage fluid culture, and trans-bronchial lung biopsy (HPE) positivity.
Conclusions: Bronchoscopic specimens are essential for accurate and rapid diagnosis of sputum Xpert MBT/RIF negative patients with high clinical and radiological suspicion of tuberculosis.
References
World Health Organization. Global tuberculosis report 2018. Available from: https://apps.who.int/iris/handle/10665/274453
World Health Organization. Tuberculosis Country Profiles (Saudi Arabia). Accessed on: 2021 Apr 15. Available from: https://www.who.int/tb/country/data/profiles/en/
Department of Statistics, Ministry of Health. Health statistical year book 2010. Riyadh Ministry of Health; 2012. Available from: https://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx
Department of statistics, Ministry of Health. Health statistical year book 2000. Riyadh: Ministry of Health; 2002. Available from: https://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx
Lee HN, Kim JI, Kim YH. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis. PLoS One 2021;16:e0250616.
Dzodanu EG, Afrifa J, Acheampong DO, Dadzie I. Diagnostic yield of fluorescence and Ziehl-Neelsen staining techniques in the diagnosis of pulmonary tuberculosis: A comparative study in a district health facility. Tuberc Res Treat 2019;2019:4091937.
Asadi L, Croxen M, Heffernan C, Dhillon M, Paulsen C, Egedahl ML, et al. How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools. EClinicalMedicine 2022;43:101250.
Pourostadi M M-Pill, Rashedi J MS, Mahdavi Poor B MS, Samadi Kafil H PhD, Hariri-Akbari M MS, Asgharzadeh M PhD. Frequency of smear-negative tuberculosis in Northwest Iran. Iran J Med Sci 2018;43:269-75.
Shi J, Dong W, Ma Y, Liang Q, Shang Y, Wang F, et al. GeneXpert MTB/RIF outperforms mycobacterial culture in detecting mycobacterium tuberculosis from salivary sputum. BioMed Res Int 2018;2018:1514381.
Machado D, Couto I, Viveiros M. Advances in the molecular diagnosis of tuberculosis: From probes to genomes. Infect Genet Evol 2019;72:93-112.
World Health Organization. WHO meeting report for a technical expert consultation: no-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF. Available from: https://apps.who.int/iris/handle/10665/254792
Kim MJ, Nam YS, Cho SY, Park TS, Lee HJ. Comparison of the Xpert MTB/RIF assay and real-time PCR for the detection of Mycobacterium tuberculosis. Ann Clin Lab Sci 2015;45:327-32.
Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, et al. Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev 2018;8:CD012768.
World Health Organization. Molecular assays intended as initial tests for the diagnosis of pulmonary and extrapulmonary TB and rifampicin resistance in adults and children: rapid communication. 2020. Available from: https://apps.who.int/iris/handle/10665/330395
Nguyen MVH, Jenny-Avital ER, Burger S, Leibert EM, Achkar JM. Clinical and radiographic manifestations of sputum culture-negative pulmonary tuberculosis. PLoS One 2015;10:e0140003.
Zaglool DA, Khodari YA, Gazzaz ZJ, Dhafar KO, Shaker HA, Farooq MU. Prevalence of intestinal parasites among patients of Al-Noor Specialist Hospital, Makkah, Saudi Arabia. Oman Med J 2011;26:182-5.
Ministry of Health. Al Noor Specialist Hospital. 2020. Available from: http://nsh.med.sa/Pages/Home.aspx
Kim YW, Kwon BS, Lim SY, Lee YJ, Cho YJ, Yoon HI, et al. Diagnostic value of bronchoalveolar lavage and bronchial washing in sputum-scarce or smear-negative cases with suspected pulmonary tuberculosis: a randomized study. Clin Microbiol Infect 2020;26:911-6.
Hendry C, Dionne K, Hedgepeth A, Carroll K, Parrish N. Evaluation of a rapid fluorescent staining method for detection of mycobacteria in clinical specimens. J Clin Microbiol 2009;47:1206-8.
He Y, Gong Z, Zhao X, Zhang D, Zhang Z. Comprehensive determination of Mycobacterium tuberculosis and Nontuberculous mycobacteria from targeted capture sequencing. Front Cell Infect Microbiol 2020;10:449.
Sun Y, Zhang Q, Zhang Q, Liu C, Zhang H, Fu Y, et al. Diagnostic efficacy of Xpert MTB/RIF assay in bronchoalveolar lavage fluid for tracheobronchial tuberculosis: A retrospective analysis. Front Med (Lausanne) 2021;8:682107.
Jacomelli M, Silva PR, Rodrigues AJ, Demarzo SE, Seicento M, Figueiredo VR. Bronchoscopy for the diagnosis of pulmonary tuberculosis in patients with negative sputum smear microscopy results. [Article in English, Portuguese]. J Bras Pneumol 2012;38:167-73.
Altaf Bachh A, Gupta R, Haq I, Varudkar HG. Diagnosing sputum/smear-negative pulmonary tuberculosis: Does fibre-optic bronchoscopy play a significant role? Lung India 2010;27:58-62.
Shin JA, Chang YS, Kim TH, Kim HJ, Ahn CM, Byun MK. Fiberoptic bronchoscopy for the rapid diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis 2012;12:141.
Charoenratanakul S, Dejsomritrutai W, Chaiprasert A. Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis. Respir Med 1995;89:621-3.
Iyer VN, Joshi AY, Boyce TG, Brutinel MW, Scalcini MC, Wilson JW, et al. Bronchoscopy in suspected pulmonary TB with negative induced-sputum smear and MTD® Gen-probe testing. Respir Med 2011;105:1084-90.
Lee HY, Seong MW, Park SS, Hwang SS, Lee J, Park YS, et al. Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis 2013;17:917-21.
Shrestha P, Arjyal A, Caws M, Prajapati KG, Karkey A, Dongol S, et al. The application of GeneXpert MTB/RIF for smear-negative TB diagnosis as a fee-paying service at a South Asian General Hospital. Tuberc Res Treat 2015;2015:102430.
Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, et al. Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulm Med 2014;14:137.
World Health Organization. Treatment of tuberculosis: Guidelines for National Programs. 2003. Accessed on: 29 September 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/67890/WHO_CDS_TB_2003.313_eng.pdf?sequence=1
Dubey S, Gaikwad N, Meshram S, Bagrecha M. Diagnostic yield of bronchoalveolar fluid/bronchoscopy among sputum AFB and CBNAAT negative presumptive tuberculosis patients: an observational study. Int J Res Med Sci 2021;9:546-51.
Ko JM, Park HJ, Kim CH, Song SW. The relation between CT findings and sputum microbiology studies in active pulmonary tuberculosis. Eur J Radiol 2015;84:2339-44.
Pfyffer GE, Wittwer F. Incubation time of mycobacterial cultures: how long is long enough to issue a final negative report to the clinician? J Clin Microbiol 2012;50:4188-9.
Gowda NC, Ray A, Soneja M, Khanna A, Sinha S. Evaluation of Xpert®Mycobacterium tuberculosis/rifampin in sputum-smear negative and sputum-scarce patients with pulmonary tuberculosis using bronchoalveolar lavage fluid. Lung India 2018;35:295-300.
Barnard DA, Irusen EM, Bruwer JW, Plekker D, Whitelaw AC, Deetlefs JD et al. The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting. BMC Pulm Med 2015;15:103.
Theron G, Peter J, Meldau R, Khalfey H, Gina P, Matinyena B, et al. Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid. Thorax 2013;68:1043-51.
Theron G, Peter J, Richardson M, Barnard M, Donegan S, Warren R, et al. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs. Cochrane Database Syst Rev 2014;(10):CD010705.
Liu Q, Ji Y, Martinez L, Lu W, Shi X, Wang J, et al. Combined tests with Xpert MTB/RIF assay with bronchoalveolar lavage fluid increasing the diagnostic performance of smear-negative pulmonary tuberculosis in Eastern China. Epidemiol Infect 2020;149:e5.
Al-Tawfiq JA, Hinedi K, Memish ZA. Systematic review of the prevalence of Mycobacterium tuberculosis resistance in Saudi Arabia. J Chemother 2015;27:378-82.
Al-Tawfiq JA, Al-Muraikhy AA, Abed MS. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. Chest 2005;128:3229-32.
Kordy FN, Al-Thawadi S, Alrajhi AA. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis 2004;8:1007-11.
Yezli S, Memish ZA. Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. J Chemother 2012;24:1-5.
Alateah SM, Othman MW, Ahmed M, Al Amro MS, Al Sherbini N, Ajlan HH. A retrospective study of tuberculosis prevalence amongst patients attending a tertiary hospital in Riyadh, Saudi Arabia. J Clin Tuberc Other Mycobact Dis 2020;21:100185.
Mondoni M, Repossi A, Carlucci P, Centanni S, Sotgiu G. Bronchoscopic techniques in the management of patients with tuberculosis. Int J Infect Dis 2017;64:27-37.
Rajagopal TV, Isaac B, Christopher DJ, Thangakunam B, Gupta R, James P. The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era. Eur Respir J 2020;56:534.
Zainudin BM, Wahab Sufarlan A, Rassip CN, Ruzana MA, Tay AM. The role of diagnostic fiberoptic bronchoscopy for rapid diagnosis of pulmonary tuberculosis. Med J Malaysia 1991;46:309-13.
Published
Issue
Section
License
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
